Gene-edited cells that evade rejection show promise in type 1 diabetes

May Be Interested In:Exclusion Diet in Pediatric Crohn's Tied to Clinical Remission in Small Study


A transmission electron micrograph of a section through pancreas tissue, showing cells that produce insulin

STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY/Alamy

The first human trial of insulin-producing cells that have been gene-edited to evade immune attack is a success so far. The cells have survived and produced insulin for a month after being injected into a 42-year-old man with type 1 diabetes early in December.

As a precaution, only a small number of insulin-producing beta cells were injected into a forearm muscle in this initial test, so the man still needs insulin injections. It also remains to be seen how long the…

share Share facebook pinterest whatsapp x print

Similar Content

traditional christmas setting
The surprising history of your favourite Christmas traditions
Trump appoints The Apprentice producer as US special envoy to UK
Trump appoints The Apprentice producer as US special envoy to UK
California fires live: progress made against some LA blazes but thickening smoke prompts ‘health emergency’
California fires live: progress made against some LA blazes but thickening smoke prompts ‘health emergency’
Big Pharma is remaining quiet on Trump's Chinese tariffs
Big Pharma is remaining quiet on Trump’s Chinese tariffs
Rotten Forgotten Demo Is Out Now on Steam
Rotten Forgotten Demo Is Out Now on Steam
The Ultimate Cold Fighting Detox Teas For Boosting Immunity In Winter
Five health apps that can be your personal trainer | Femina.in
Real News, Real People: Impactful Stories of Today | © 2025 | Daily News